Effects of Furosemide Plus Small HSS in Subjects With Heart Failure With Reduced Ejection Fraction (HFrEF)

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 136 participants.

Also called NCT04628325

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 136 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT04628325
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Italy (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT04628325. Randomized; single masking; primary purpose treatment. Start 2017-03-01 (actual); primary completion 2019-06-30 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Effects of Furosemide Plus Small HSS in Subjects With Heart Failure With Reduced Ejection Fraction (HFrEF)
Condition
Heart Failure,Congestive
Intervention (Drug)
Furosemide
Lead sponsor
University of Palermo (class: other)

Record details

Record id
cardio:ct-nct04628325
Content hash
52fc16309c0529cf4e6f002e4b566a47ceba0b95052d395eede288cf9a7eb9dd